Related Experiment Video
Updated: Apr 5, 2026

Measurement of Chitinase Activity in Biological Samples
Published on: August 22, 2019
Role of acetylcholinesterase in lung cancer
Hui-Jun Xi1, Ren-Pei Wu1, Jing-Jing Liu2
1Digestive Endoscopy Center, Changhai Hospital, Second Military Medical University Shanghai, China.
Abstract:
Acetylcholinesterase (AChE) plays a key role in catalytic hydrolysis of cholinergic neurotransmitters. Intensive research has proven the involvement of this protein in novel functions, such as cell adhesion, differentiation, and proliferation. In addition, several recent studies have indicated that acetylcholinesterase is potentially a marker and regulator of apoptosis. Importantly, AChE is also a promising tumor suppressor. In this review, we briefly summarize the involvement of AChE in apoptosis and cancer, focusing on the role of AChE in lung cancer, as well as the therapeutic consideration of AChE for cancer therapy.
Insights
Acetylcholinesterase (AChE) regulates apoptosis and shows promise as a tumor suppressor. This review highlights AChE's role in lung cancer and its therapeutic potential for cancer treatment.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Acetylcholinesterase (AChE) is crucial for neurotransmission via cholinergic hydrolysis.
- Emerging research reveals AChE's involvement in cell adhesion, differentiation, proliferation, and apoptosis.
- AChE is recognized as a potential tumor suppressor with implications in various cancers.
Purpose of the Study:
- To review the multifaceted roles of AChE in apoptosis.
- To elucidate the significance of AChE in cancer development and progression.
- To explore the therapeutic potential of AChE in cancer treatment, with a focus on lung cancer.
Main Methods:
- Literature review of recent studies on AChE.
- Analysis of AChE's function in cellular processes including apoptosis.
- Examination of AChE's role in lung cancer pathogenesis.
- Evaluation of AChE-targeted cancer therapies.
Main Results:
- AChE influences cell signaling pathways regulating apoptosis.
- AChE expression levels correlate with tumor suppression in certain cancers.
- Dysregulation of AChE is observed in lung cancer, impacting prognosis.
- AChE modulation presents a potential therapeutic strategy for cancer.
Conclusions:
- AChE is implicated in both apoptosis regulation and tumor suppression.
- Targeting AChE offers a promising avenue for novel lung cancer therapies.
- Further research into AChE's mechanisms can unlock its full therapeutic potential.
Related Concept Videos
Cholinesterases: Distribution and Function
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Indirect-Acting Cholinergic Agonists: Pharmacokinetics
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
